| MSOF | multiple systems organ failure |
|---|---|
| OSI | open systems interconnection [reference model] |
| POIS | Parkland On-Line Information Systems |
| ROS | reactive oxygen species; review of systems; rod outer segment |
| SMS | senior medical student; serial motor seizures; Shared Medical Systems; Smith-Magenis syndrome; somat... |
| antimutagenic agents | Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved. (12 Dec 1998) |
|---|---|
| anti-obesity agents | Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (niddm) to treat obesity. (12 Dec 1998) |
| antiparasitic agents | Drugs used to treat or prevent parasitic infections. (12 Dec 1998) |
| antiparkinson agents | Agents used in the treatment of parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (12 Dec 1998) |
| anti-platelet agents | Medications that, like aspirin, reduce the tendency of platelets in the blood to clump and clot. (12 Dec 1998) |
| antiplatyhelmintic agents | Agents used to treat cestode, trematode, or other flatworm infestations in man or animals. (12 Dec 1998) |
| antiprotozoal agents | Agents destructive to protozoans or that check their growth or reproduction, especially those causing protozoan infections in man and animal. (12 Dec 1998) |
| antipsychotic agents | Agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in schizophrenia, senile dementia, transient psychosis following surgery or myocardial infarction, etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (12 Dec 1998) |
| antipsychotic agents, butyrophenone | Those butyrophenone derivatives used in the treatment of psychoses. (12 Dec 1998) |
| antipsychotic agents, phenothiazine | Phenothiazine derivatives used in the treatment of psychoses. (12 Dec 1998) |
| antirheumatic agents | Drugs that are used to treat rheumatoid arthritis. (12 Dec 1998) |
| antirheumatic agents, gold | Gold salts that are effective in the therapy of rheumatoid arthritis. These compounds usually do not have analgesic activity. Since these compounds are poorly absorbed from the intestinal tract, they are usually given intramuscularly. (12 Dec 1998) |
| antisickling agents | Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions. (12 Dec 1998) |
| antispermatogenic agents | Agents, either mechanical or chemical, which destroy spermatozoa in the male genitalia and block spermatogenesis. (12 Dec 1998) |
| antithyroid agents | Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones. (12 Dec 1998) |